Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant.
Susan Prockop,Ekaterina Doubrovina,Stephanie Suser,Glenn Heller,Juliet Barker,Parastoo Dahi,Miguel A Perales,Esperanza Papadopoulos,Craig Sauter,Hugo Castro-Malaspina,Farid Boulad,Kevin J Curran,Sergio Giralt,Boglarka Gyurkocza,Katharine C Hsu,Ann Jakubowski,Alan M Hanash,Nancy A Kernan,Rachel Kobos,Guenther Koehne,Heather Landau,Doris Ponce,Barbara Spitzer,James W Young,Gerald Behr, Mark Dunphy,Sofia Haque,Julie Teruya-Feldstein,Maria Arcila,Christine Moung,Susan Hsu,Aisha Hasan,Richard J O'Reilly JOURNAL OF CLINICAL INVESTIGATION（2020）
Key words
Cancer immunotherapy,Immunology,T cells,Transplantation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper